Investors

Investors Overview

Champions Oncology, Inc. is engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s Champions TumorGraft® technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune-deficient mice followed by propagation of the resulting engraftments, or patient-derived xenograft (PDX) models, in a manner that preserves the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen. The company uses this technology in conjunction with related services to offer solutions for two customer groups: Personalized Oncology Solutions, in which results help guide the development of personalized treatment plans, and Translational Oncology Solutions, in which pharmaceutical and biotechnology companies seeking personalized approaches to drug development can lower the cost and increase the speed of developing new drugs. Champions TumorGraft PDX models are procured through agreements with a number of institutions in the U.S. and overseas as well as through the company’s Personalized Oncology Solutions business.

Download the Champions Investor Presentation

Sign Up for Email Alerts from Champions Oncology

 Download Quarterly Earnings Call

 

MicrophoneFY 2018 Q2 Earnings Call

Microphone

FY 2018 Q1 Earnings Call

Microphone

FY2017 Q4 Earnings Call

MicrophoneFY2017 Q3 Earnings Call

MicrophoneFY2017 Q2 Earnings Call

Microphone

FY2017 Q1 Earnings Call

Microphone Archived Calls

 

 

 

Real-Time Stock Chart

Yahoo finance API is not available right now, please try again soon...

Champions Oncology - Specializing in | Personalized Cancer Therapy | Translational Oncology Solutions | Oncology drug development | Oncology drug discovery | Translational oncology | Translation oncology research | Predictive oncology | Patient-derived xenograft model | Tumorgrafts | Alternative/new cancer treatment | Anticancer therapies | Personalized cancer treatment | Personalized cancer therapy | Personalized oncology